Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease

Ovarian cancers (OvC) are frequent, with more than 22,000 new cases each year for 14,000 deaths in the United States. Except for patients with BRCA1 or BRCA2 mutations, diagnostic methods, prognostic tools, and therapeutic strategies have not much improved in the last two decades. High throughput tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mari, Roxane, Mamessier, Emilie, Lambaudie, Eric, Provansal, Magali, Birnbaum, Daniel, Bertucci, François, Sabatier, Renaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627130/
https://www.ncbi.nlm.nih.gov/pubmed/31167492
http://dx.doi.org/10.3390/cancers11060774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627130/
https://www.ncbi.nlm.nih.gov/pubmed/31167492
http://dx.doi.org/10.3390/cancers11060774

Ejemplares similares